Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department

Emergency Medicine Journal

Volumn 32, Issue 7, 2015, Pages 509-515

  Borde, Johannes P ^a   Kern, Winfried V ^a   Hug, Martin ^a   Steib Bauert, Michaela ^a   De With, Katja ^a,b   Busch, Hans Jörg ^a   Kaier, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CLINDAMYCIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; QUINOLONE DERIVATIVE;

ARTICLE; DEFINED DAILY DOSE; DRUG DOSE; DRUG USE; EMERGENCY WARD; HEALTH PROGRAM; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; ANTIBIOTIC RESISTANCE; DRUG UTILIZATION; EMERGENCY HEALTH SERVICE; GERMANY; INFORMATION PROCESSING; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; EMERGENCY SERVICE, HOSPITAL; FLUOROQUINOLONES; FOCUS GROUPS; GERMANY; HOSPITALS, UNIVERSITY; HUMANS;

EID: 84932118725     PISSN: 14720205     EISSN: 14720213     Source Type: Journal    
DOI: 10.1136/emermed-2014-204067     Document Type: Article

References (34)

1. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013;13:1057-98.
2. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159-77.
3. Tamma PD, Cosgrove SE. Antimicrobial stewardship. Infect Dis Clin North Am 2011;25:245-60.
4. Young EJ, Sewell CM, Koza MA, et al. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 1985;290:223-7.
5. Gerding DN. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol 2000;21:S12-17.
6. Kaier K. Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections. Value Health 2012;15:87-93.
7. Dancer SJ, Kirkpatrick P, Corcoran DS, et al. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2013;41:137-42.
8. Livermore DM, Hope R, Reynolds R, et al. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 2013;68:2667-74.
9. Kaier K, Hagist C, Frank U, et al. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:346-53.
10. Pépin J, Saheb N, Coulombe M-A, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005;41:1254-60.
11. Talpaert MJ, Gopal Rao G, Cooper BS, et al. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011;66:2168-74.
12. Lafaurie M, Porcher R, Donay J-L, et al. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother 2012;67:1010-15.
13. LeBlanc L, Pépin J, Toulouse K, et al. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2006;12:1398-405.
14. Aldeyab MA, Scott MG, Kearney MP, et al. Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings. Epidemiol Infect 2014;142:494-500.
15. Petrikkos G, Markogiannakis A, Papaparaskevas J, et al. Differences in the changes in resistance patterns to third-and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospita. Int J Antimicrob Agents 2007;29:34-8.
16. Aldeyab MA, Harbarth S, Vernaz N, et al. The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 2012;74:171-9.
17. Skrlin J, Bacic Vrca V, Marusic S, et al. Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption. J Chemother 2011;23:341-4.
18. Standiford HC, Chan S, Tripoli M, et al. Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol 2012;33:338-45.
19. Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2013;4:CD003543.
20. Robinson HL, Robinson PC, Whitby M. Poor Compliance with Community-Acquired Pneumonia Antibiotic Guidelines in a Large Australian Private Hospital Emergency Department. Microb Drug Resist Published Online First: 20 June 2014. doi:10.1089/mdr.2014.0064
21. Kaur S, Rajagopalan S, Kaur N, et al. Drug utilization study in medical emergency unit of a tertiary care hospital in north India. Emerg Med Int 2014;2014:973578.
22. Pallin DJ, Camargo CA, Schuur JD. Skin infections and antibiotic stewardship: analysis of emergency department prescribing practices, 2007-2010. West J Emerg Med 2014;15:282-9.
23. Fagan M, Lindbæk M, Reiso H, et al. A simple intervention to reduce inappropriate ciprofloxacin prescribing in the emergency department. Scand J Infect Dis 2014;46:481-5.
24. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012;55:651-62.
25. Schuetz P, Chiappa V, Briel M, et al. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011;171:1322-31.
26. Schuetz P, Briel M, Mueller B. Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections. JAMA 2013;309:717-18.
27. Borde JP, Kaier K, Steib-Bauert M, et al. Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center. BMC Infect Dis 2014;14:201.
28. Long W, Deng X, Zhang Y, et al. Procalcitonin guidance for reduction of antibiotic use in low-risk outpatients with community-acquired pneumonia. Respirology 2011;16:819-24.
29. Demonchy E, Dufour J-C, Gaudart J, et al. Impact of a computerized decision support system on compliance with guidelines on antibiotics prescribed for urinary tract infections in emergency departments: a multicentre prospective before-and-after controlled interventional study. J Antimicrob Chemother Published Online First: 4 June 2014. doi:10.1093/jac/dku191
30. Stein JC, Navab B, Frazee B, et al. A randomized trial of computer kiosk-expedited management of cystitis in the emergency department. Acad Emerg Med 2011;18:1053-9.
31. Ramsay C, Brown E, Hartman G, et al. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003;52:764-71.
32. Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
33. Ramsay CR, Matowe L, Grilli R, et al. Interrupted time series designs in health technology assessment: lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 2003;19:613-23.
34. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/21%20Interrupted% 20time%20series%20analyses%202013%2008%2012.pdf